Target intelligence / Profile preview

Lymphatic vessels and capillaries

Molecular classification
Other
01

Overview

Lymphatic vessels and capillaries are a specialized vascular network essential for maintaining tissue fluid balance, facilitating immune cell trafficking, and absorbing dietary lipids. Unlike the closed blood circulatory system, the lymphatic system is a unidirectional drainage network that begins with blind-ended capillaries in the interstitial spaces of most tissues (NIH, 2023). These vessels are lined by a single layer of lymphatic endothelial cells (LECs) that possess unique structural features, such as button-like junctions in capillaries that allow for the entry of large molecules and cells (PubMed, 2021). In oncology, lymphatic vessels serve as a primary route for the metastatic spread of tumor cells to regional lymph nodes, a process often driven by tumor-secreted growth factors like VEGF-C (PubMed, 2022). Therapeutic targeting of the lymphatic system includes the use of mTOR and PI3K inhibitors to treat lymphatic malformations and the investigation of VEGFR-3 inhibitors to block lymphangiogenesis in cancer (StatPearls, 2023). Understanding the molecular regulation of these vessels is crucial for developing treatments for lymphedema, chronic inflammation, and various vascular overgrowth syndromes.

Other names
Lymphatic systemLymphatic vasculatureLymphaticsLymphatic network
02

Mechanism of action

Modulation of lymphangiogenesis through inhibition of the VEGF-C/VEGFR-3 signaling pathway; inhibition of the PI3K/AKT/mTOR pathway to control lymphatic endothelial cell growth and malformation; reduction of lymphatic permeability and interstitial fluid pressure.

03

Biological functions

Fluid homeostasisImmune cell transportLipid absorptionWaste clearanceAntigen presentation support
04

Disease associations

Cancer metastasisLymphedemaLymphatic malformationsInflammationCardiovascular diseaseObesity
05

Safety considerations

Secondary lymphedemaImpaired immune cell traffickingDelayed wound healingAltered lipid absorptionSystemic fluid imbalance
06

Interacting drugs

Sirolimus

5 more in the full profile.

07

Biomarkers

Podoplanin (D2-40)LYVE-1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1)PROX1 (Prospero Homeobox 1)VEGFR-3 (Vascular Endothelial Growth Factor Receptor 3)CCL21

Beyond the preview

Go deeper on Lymphatic vessels and capillaries.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic vessels and capillaries.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call